Q/C Technologies, Inc. (QCLS)Technology | Computer Hardware | New York, United States | NasdaqCM
3.83 USD
+0.07
(1.729%)
⇧
(April 21, 2026, 1:42 p.m.
EDT)
Short-term: ★★★★☆ | Long-term: ★☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 19, 2026, 12:32 a.m. EDT
Near-term optical AI narrative and recent price rebound offer a low-conviction bullish entry, but the stock suffers from negative earnings, high volatility (indicated by low Ljung-Box p-value), and a complete lack of dividends, making it a weak long-term fundamental hold. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.111607 |
| AutoETS | 0.111618 |
| MSTL | 0.161501 |
| AutoTheta | 0.230934 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 34% |
| H-stat | 2.42 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.002 |
| Excess Kurtosis | 1.51 |
| Attribute | Value |
|---|---|
| Sector | Technology |
| Market Cap | 30,039,366 |
| Beta | 2.15 |
| Previous Name | MyMD Pharmaceuticals, Inc. |
| Website | https://www.qctechnologies.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.78876406 |
| Address1 | 1,185 Avenue of the Americas |
| Address2 | Suite 249 |
| All Time High | 6,566,400.0 |
| All Time Low | 2.5 |
| Ask | 4.86 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 330,720 |
| Average Daily Volume3 Month | 1,066,726 |
| Average Volume | 1,066,726 |
| Average Volume10Days | 330,720 |
| Beta | 2.151 |
| Bid | 3.04 |
| Bid Size | 1 |
| Book Value | 2.81 |
| City | New York |
| Compensation As Of Epoch Date | 1,735,603,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 3.825 |
| Current Ratio | 2.997 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 4.25 |
| Day Low | 3.75 |
| Display Name | Q/C |
| Ebitda Margins | 0.0 |
| Enterprise Value | 16,840,334 |
| Eps Trailing Twelve Months | -8.66 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 3.7596 |
| Fifty Day Average Change | 0.06540012 |
| Fifty Day Average Change Percent | 0.0173955 |
| Fifty Two Week Change Percent | -78.8764 |
| Fifty Two Week High | 33.6 |
| Fifty Two Week High Change | -29.774998 |
| Fifty Two Week High Change Percent | -0.8861607 |
| Fifty Two Week Low | 2.5 |
| Fifty Two Week Low Change | 1.325 |
| Fifty Two Week Low Change Percent | 0.53000003 |
| Fifty Two Week Range | 2.5 - 33.6 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,390,487,400,000 |
| Float Shares | 7,587,669 |
| Free Cashflow | -6,862,920 |
| Full Exchange Name | NasdaqCM |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.04349 |
| Held Percent Institutions | 0.09585 |
| Implied Shares Outstanding | 7,853,429 |
| Industry | Computer Hardware |
| Industry Disp | Computer Hardware |
| Industry Key | computer-hardware |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,756,771,200 |
| Last Split Factor | 1:100 |
| Long Business Summary | Q/C Technologies, Inc., a clinical-stage pharmaceutical company, focuses on developing and commercializing therapeutic platforms based on various therapeutic targets. The company develops Isomyosamine, a clinical stage small molecule that regulates the immunometabolic system to treat autoimmune disease, including sarcopenia, frailty, adverse effects of drugs used to treat diabetes and obesity, rheumatoid arthritis, and inflammatory bowel disease. It also develops Supera-CBD, a synthetic analog of derivative of cannabidiol (CBD) to treat various conditions, including epilepsy, pain and anxiety/depression. The company also develops a silicon photonic computing architecture for AI inference. The company has a strategic alliance with DADA2 Foundation for research into the rare inflammatory disease DADA2 (Deficiency of Adenosine Deaminase 2). The company was formerly known as TNF Pharmaceuticals, Inc. and changed its name to Q/C Technologies, Inc. in September 2025. The company was founded in 2014 and is headquartered in New York, New York. |
| Long Name | Q/C Technologies, Inc. |
| Market | us_market |
| Market Cap | 30,039,366 |
| Market State | REGULAR |
| Max Age | 86,400 |
| Message Board Id | finmb_694917951 |
| Most Recent Quarter | 1,767,139,200 |
| Name Change Date | 2,026-04-20 |
| Net Income To Common | -14,984,446 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 29,623,134 |
| Open | 3.75 |
| Operating Cashflow | -9,065,619 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 856 848 8698 |
| Prev Name | MyMD Pharmaceuticals, Inc. |
| Previous Close | 3.76 |
| Price Hint | 4 |
| Price To Book | 1.36121 |
| Profit Margins | 0.0 |
| Quick Ratio | 2.857 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.06500006 |
| Regular Market Change Percent | 1.728725 |
| Regular Market Day High | 4.25 |
| Regular Market Day Low | 3.75 |
| Regular Market Day Range | 3.75 - 4.25 |
| Regular Market Open | 3.75 |
| Regular Market Previous Close | 3.76 |
| Regular Market Price | 3.825 |
| Regular Market Time | 1,776,793,323 |
| Regular Market Volume | 634,990 |
| Return On Assets | -0.19139 |
| Return On Equity | -0.58954 |
| Sand P52 Week Change | 0.34445214 |
| Sector | Technology |
| Sector Disp | Technology |
| Sector Key | technology |
| Shares Outstanding | 7,853,429 |
| Shares Percent Shares Out | 0.1841 |
| Shares Short | 1,445,914 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 1,064,527 |
| Short Name | Q/C Technologies, Inc. |
| Short Percent Of Float | 0.1924 |
| Short Ratio | 1.4 |
| Source Interval | 15 |
| State | NY |
| Symbol | QCLS |
| Total Cash | 15,806,463 |
| Total Cash Per Share | 2.013 |
| Total Debt | 0 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -8.66 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 5.35875 |
| Two Hundred Day Average Change | -1.5337498 |
| Two Hundred Day Average Change Percent | -0.2862141 |
| Type Disp | Equity |
| Volume | 634,990 |
| Website | https://www.qctechnologies.com |
| Zip | 10,036 |